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Abstract
Background Diagnosing tuberculosis in children is difficult, 
with under-diagnosis or over-diagnosis commonly occurring. 
The tuberculin test as a supporting examination for tuberculosis 
infection has a false negative value rate of 10-25%. Also, a 
majority of children with tuberculosis have lower plasma zinc levels 
than healthy children. Zinc deficiency may impair the immune 
response, leading to more false negative skin-test results.
Objective To evaluate the effectiveness of topical zinc for 
augmenting the diameter of tuberculin induration in children 
with tuberculosis.
Methods This unblinded, clinical trial was performed from 
October to December 2012 in subjects matched with themselves. 
Subjects were children with tuberculosis aged 2-18 years at the 
Department of Child Health at Cipto Mangunkusumo Hospital 
and Persahabatan Hospital. every subject was injected tuberculin 
in volar region of left and right arm. Test sites then were covered 
with topical zinc cream on the right arm and placebo cream on 
the left arm. Indurations were measured after 72 hours. The 
difference of tuberculin diameter of 3 mm was considered as 
clinically significant. Data analysis was performed with Wilcoxon 
signed rank test.  
Results There were 47 subjects in this study. The majority of 
subjects were well-nourished (53%). Subjects’ median treatment 
duration was < 6 months, median age was 72 months and 47% 
of subjects were under the age of five years. Sixteen subjects had 
a median 1 mm difference in tuberculin induration diameter 
between the zinc arm and placebo arm (P<0.001), but this was 
clinically insignificant. Twenty-two subjects (43%) had Koch 
reaction after zinc cream application, but the placebo cream did 
not cause Koch reaction. 
Conclusion Application of topical zinc does not increase 
tuberculin induration compared to placebo. 
[Paediatr Indones. 2013;53:273-7.].
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D
iagnosis of tuberculosis (TB) in children 
is difficult. microbiological examination 
as the gold standard often shows negative 
results due to the limited quantity of bacilli 
present and difficulty extracting specimens from 
distant lung parenchyma sites.  Also, as a diagnostic 
tool for Tb infection, the tuberculin test has a high 
false negative rate of 10-25%. The tuberculin test 
is influenced by cellular immunity. As such, factors 
influencing cellular immunity may contribute 
to false negative results including malnutrition, 
immunodeficiency, immunocompromised state, severe 
Tb, as well as procedural errors in preparation or 
injection of the tuberculin test.1-3 
micronutrient deficiency is common in both 
adults and children with Tb. Since zinc is involved 
in cellular immunity, zinc deficiency may cause 
false negative result of tuberculin test. Fortunately, 
this condition is reversible upon supplementation.4 
Children with Tb have lower plasma zinc levels than 
healthy children.5 In addition, Tb patients with 
negative tuberculin tests have lower plasma zinc 
levels than those with positive tests.6 Furthermore, a 
study of 30 children with TB found that plasma zinc 
levels were lowest prior to initiation of tuberculosis Anisa Rahmadhany et al: The use of topical zinc in tuberculin test
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medication, but increased along with administration of 
anti-tuberculosis drugs.6 To date, studies using topical 
zinc cream in tuberculin test is limited for adult Tb 
patients.7,8 We aimed to evaluate the effectiveness of 
topical zinc for increasing the diameter of tuberculin 
induration in children with tuberculosis.
Methods
This unblinded, clinical trial was conducted from 
October to December 2012 in the Department 
of Child Health at Cipto mangunkusumo and 
Persahabatan Hospitals. Subjects were children with 
TB aged 2-18 years, with positive tuberculin tests at 
the time of diagnosis, and who had undergone ≤1 
year of tuberculosis therapy. We excluded patients 
with immu  nocompromised conditions (severe 
malnutrition, HIV, malignancy, in steroid therapy for 
more than 2 weeks or in chemotherapy), those who 
were within 6 weeks post-viral disease (varicella or 
measles) or within 6 weeks post-vaccination (varicella 
or measles). Subjects were matched with themselves, 
by comparing the right and left arm results. The 
minimum required sample size was calculated to be 
43, along with an estimated 10% dropping out, so we 
arrived at a total sample size of 47 subjects. Subjects 
were recruited by consecutive sampling.
This study was approved by the ethics Commitee 
of the university of Indonesia medical School. All pati-
ents and parents were given a complete explanation of 
the study. Subjects‘ parents provided written informed 
consent. After parental approval, baseline characte-
ristics were measured and recorded. In an unblinded 
manner, tuberculin tests (0.1 mL PPD RT 23 2 TU 
Biofarma®) were injected in the left arm and covered 
with 1 spoon of placebo cream (manufactured by 
FMIPA/Faculty of Mathematics and Science University 
of Indonesia), while the tuberculin test injected in 
the right arm was covered with 1 spoon of zinc sulfate 
dissolved in aqueous cream at a concentration of 10% 
elemental zinc (manufactured by FMIPA/Faculty of 
Mathematics and Science University of Indonesia). 
One spoon contains 20 mg either placebo or zinc cream 
that were applied directly at the injection site and its 
surrounding skin. Tuberculin test sites were immediately 
covered with an occlusive dressing (Tegaderm®). On the 
right arm, zinc sulfate cream was additionally applied 5 
cm from the site of tuberculin injection and also covered 
with occlusive dressing, while no placebo cream was 
applied on the left arm except at the tuberculin test 
injection site. After 72 hours, the dressing and cream 
were removed, and the “ballpoint pen” test was used 
to measure indurations. Koch reaction was defined as 
induration of tuberculin that accompanied by pain or 
skin reaction (vesicles, bullaes, necrosis). We made 2 
comparisons: zinc arm induration size compared to 
indurations size at the time of diagnosis and zinc arm 
induration size compared to placebo arm induration 
size. The difference of tuberculin diameter of 3 mm was 
considered as clinically significant. Wilcoxon test was 
used to analyze differences in diameters of tuberculin 
test indurations between the two arms whereas mc-
nemar test was used to analyze Koch reaction. A P value 
of < 0.05 was considered as statistically significant. 
Statistical analysis was performed using SPSS 15.0.
Results
one hundred patients fulfilled the study criteria, 
with 10 who refused to enroll and 43 who were not 
recruited as 47 subjects were already enrolled (Figure 
1). Subjects‘ median age was 72 (range 24-192) months 
and 47% subjects were under five years of age. The 
majority of subjects were well-nourished (53%), had 
lung TB (81%) and had received BCG vaccinations 
(85%). The median duration of TB treatment in our 
subjects was 6 months (Table 1).
Figure 1. Flow chart of subjects selection
100 subjects fulfilled study criteria
10 subjects refused to 
participate in the study
43 subjects were not recruited 
47 subjects were enrolled in the study
Consecutive samplingAnisa Rahmadhany et al: The use of topical zinc in tuberculin test
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We observed induration augmentation in the 
arm that received topical zinc cream in 16 subjects, 
but not in the other 31 subjects. Diameters of tu-
berculin induration in zinc arms were all equal to or 
greater than those of the placebo arms. The median 
difference in tuberculin induration for all subjects 
was 1 mm (P<0.001, Wilcoxon test, Table 2), but 
was clinically insignificant. Comparison of induration 
diameter at the time of diagnosis to the diameter of 
the placebo arm yielded the following results: 35 
subjects with similar diameter, 8 subjects with in-
creased diameter in the placebo arm and 4 subjects 
with decreased diameter in the placebo arm. of the 
16 subjects with tuberculin augmentation in the zinc 
arm, 9 were undernourished and 12 had undergone 
tuberculosis therapy for ≤6 months.
The application of topical zinc cream 5 cm from 
the tuberculin test site did not cause hypersensitivity 
reactions. Nevertheless, application of topical zinc 
cream after injection of tuberculin test caused Koch 
reaction (vesicles or pustules) at the injection site in 
20 subjects (43%) (Table 3). Of those subjects, 11/20 
were undernourished and 17/20 had durations of anti-
tuberculosis therapy of ≤6 months. Koch reactions 
were self-limiting along with waning of tuberculin 
induration over 1-2 weeks. Application of placebo 
cream after injection of tuberculin test did not cause 
Koch reaction in any subjects.
Table 1. Baseline characteristics of subjects
Characteristics N=47
Gender, n (%) 
Male
Female
Median age (range), months 
Nutritional status, n (%) 
Overweight
Well-nourished
Undernourished
BCG vaccination, n (%) 
Yes
No
Type of TB, n (%) 
Lung TB
Meningitis TB
Spondylitis TB
Others TB (scleral TB, ovarian TB, TB lymphadenitis and  TB osteomyelitis)
23 (49)
24 (51)
72 (24-192)
  2 (4)
25 (53)
20 (43)
40 (85)
  7 (15)
38 (81)
  2 (4)
  3 (6)
  4 (9)
Median TB treatment duration (range), months 
Median induration diameter at the time of diagnosis (range), mm 
  6 (2-11)
14 (10-23)
Table 2.  Differences in diameter induration between the zinc arm and placebo arm
Variables
Zinc arm
N=-47                                                       
Placebo arm
N=47
P
value1
Median tuberculin induration (min-max), mm 
Tuberculin induration based on nutritional status (min-max), mm 
Overweight
Well-nourished
Undernourished
16 (10-21)
17.5 (15-20)
15 (10-21)
17 (10-21)
15 (10-20) 
15 (15-17) 
15 (10-20)
15 (10-20) 
<0.001
0.317
0.026
0.007 
1 Wilcoxon test
Table 3. Koch reaction in all tuberculin tests (n=94)
Variables
Koch reaction
Total                 P  value1
+ -
Zinc arm 20  27  47                    <0.001
Placebo arm 0  47  47 
Total 20 74  94 
1McNemar testAnisa Rahmadhany et al: The use of topical zinc in tuberculin test
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Discussion
Studies using topical zinc cream to augment tuberculin 
induration are limited to adults only. Children with 
Tb are known to have lower plasma zinc levels than 
healthy children, and those with negative tuberculin 
tests also have lower plasma zinc than those with 
positive tests. This study is the one of the first to use 
topical zinc cream to attempt to augment tuberculin 
induration in children. limitations of this study were 
its unblinded design, measurement bias, limitation of 
consecutive sampling, unknown subjects’ plasma zinc 
levels, and no restriction of diet containing zinc. 
The median age of subjects was 72 months, with 
43% of our subjects in the under-five-year-old group, 
similar to subjects in previous studies.6,9 The majority 
of the subjects were well-nourished because subject 
recruitment was anytime during their tuberculosis 
treatment, similar to Soegiarto’s study,6 but different 
from the study by ray et al.5 We observed that 80% 
of our subjects had lung tuberculosis, which is to be 
expected since the lung is the main port of entry for 
tuberculosis infection, similar to a previous study.10
How zinc influences cutaneous cellular immunity 
remains unclear. In general, zinc is a cofactor of 
thymulin, a hormone produced in the thymus, which 
affects T-lymphocyte maturity. Zinc deficiency reduces 
the chemotactic response of neutrophils, monocytes, 
and macrophages. Cytokines, as modulators of the 
immune system, are also influenced by zinc. Secretion 
of interleukin-1, interleukin-6, tumor necrosis 
factor-alpha, and interferon-gamma by leukocytes 
is stimulated by zinc.11-13 In the skin, it has been 
proposed that zinc can augment the cutaneous 
immune response after tuberculin injection. Zinc 
affects the interaction between antigen-presenting 
cells and T-helper cells at the injection site. Cytokines 
secretion and leukocytes recruitment in delayed 
type hypersensitivity after tuberculin injection are 
stimulated by zinc.14,15
The cellular immune response to tuberculin test 
may wane in the years after the first test. Variability 
of test results following repeated tuberculin testing 
may be due to biological phenomenon, variability in 
reading and administration of the test. Inter-reader 
variability resulted in standard deviations of readings 
of 2.3 mm or 2.5 mm. Variability was less with the same 
reader (intra-reader), however, standard deviations of 
1.3 to 1.9 mm were still seen. All factors contributed 
to result variability to 3 mm.17
We found that application of topical zinc cream 
on the site of the tuberculin test yielded a median 
induration 1 mm larger than the application of placebo 
cream (P<0.001). We had previously determined a 
3-mm difference of transversal induration diameter 
to be clinically significant. Wilcoxon test revealed 
the 1 mm difference to be statistically significant, 
but it was clinically insignificant. Previous studies did 
not explicitly state the difference in mm of diameter 
induration.7,8,16   
Among 16 subjects who showed augmentation 
of tuberculin induration in the zinc arm most were 
undernourished and had undergone tuberculosis 
therapy for ≤6 months. Specifically, subjects who were 
undernourished had a higher median augmentation of 
2 mm. Undernourished children generally have lower 
plasma zinc levels. based on previous studies,6 zinc 
plasma level after 2 months of tuberculosis treatment 
has reached normal level so application of topical 
zinc cream possibly didn’t cause augmentation of 
tuberculin induration beyond that period.
In our study, application of topical zinc on the 
site of tuberculin injection sometimes yielded Koch 
reaction (vesicles or pustules). However, applica-
tion of placebo cream on the site of tuberculin injec-
tion or application of topical zinc cream alone did 
not cause any Koch reaction. one study reported 
no hypersensitivity reaction after topical zinc ap-
plication,7 while two other studies gave no report 
on hypersensitivity reactions in their subjects.8,16 
Koch reaction is due to zinc’s role in increasing 
cellular immunity resulting in greater inflammatory 
responses. Koch reaction and positive tuberculin 
test often indicate natural tuberculosis infections. 
Sensitivity and specificity of Koch reaction for tu-
berculosis infection were reported to be 77.2% and 
98%, respectively.18
In conclusion, topical zinc application is clinically 
insignificant to augment the diameter of tuberculin 
test induration. Koch reaction after topical zinc 
application is due to zinc’s role in increasing cellular 
immunity and will resolve by itself. We propose further 
follow-up studies with better methodology, such as 
a blinded study design, larger number of subjects, 
subjects with undernourished nutritional status, and 
plasma zinc level examinations.Anisa Rahmadhany et al: The use of topical zinc in tuberculin test
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